DIAGNAMED HOLDINGS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 CAD | -11.11% |
|
+14.29% | +33.33% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 3.2M 4.38M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -1.37M | Net income 2023 | -1M -1.37M | EV / Sales 2022 * | - |
| Net cash position 2022 | 1.57M 2.15M | Net cash position 2023 | 607K 830K | EV / Sales 2023 | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-2.45
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.96% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -11.11% | ||
| 1 week | +14.29% | ||
| 1 month | -11.11% | ||
| 3 months | +33.33% | ||
| Current year | +33.33% |
1 week
0.03
0.05
1 month
0.030.06
Current year
0.020.07
1 year
0.020.10
3 years
0.020.12
5 years
0.020.12
10 years
0.020.12
| Managers | Title | Age | Since |
|---|---|---|---|
Fabio Chianelli
CEO | Chief Executive Officer | - | 21-08-10 |
Jing Peng
DFI | Director of Finance/CFO | 47 | 21-08-10 |
Bassma Ghali
PRN | Corporate Officer/Principal | - | 23-03-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Jang
BRD | Director/Board Member | 63 | 21-12-31 |
Fabio Chianelli
CEO | Chief Executive Officer | - | 21-08-10 |
Carlo Sansalone
BRD | Director/Board Member | - | 23-02-12 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.04 | -11.11% | 35,000 |
| 24-04-25 | 0.045 | +28.57% | 69,000 |
| 24-04-24 | 0.035 | 0.00% | 74,000 |
| 24-04-23 | 0.035 | 0.00% | 45,015 |
| 24-04-22 | 0.035 | 0.00% | 3,150 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 11:16 am
More quotes
DiagnaMed Holdings Corp. is a Canada-based generative artificial intelligence healthcare company. The Company is focused on developing and commercializing CERVAI, a proprietary brain health artificial intelligence (AI) platform. CERVAI leverages generative AI that predicts and monitors brain age and provides actionable insights and tools to diagnose, prevent or improve cognitive decline for mental health and neurodegenerative disorders. The Company is developing and commercializing a suite of generative AI solutions powered by OpenAI's ChatGPT to support the healthcare market in improving patient outcomes, operational workflow and efficiency. AI Medical Chatbot is a personal medical chatbot designed to give people a way to obtain fast and personalized medical information based on a personâs unique medical condition.
Sector
Software
Calendar
2024-05-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +33.33% | 2.34M | |
| +8.05% | 3,020B | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| +31.16% | 50.15B | |
| -24.56% | 46.55B | |
| +17.75% | 41.41B | |
| +55.21% | 35.63B | |
| -10.24% | 24.64B |
- Stock Market
- Equities
- DMED Stock
